HEPATOCYTES--TRANSPLANTATION AND EXTRACORPOREAL LIVER SUPPORT

许多肝衰竭患者会在等待期间死亡 移植 一种生物人工肝辅助系统（BAL）， 使用猪肝细胞，已经被开发出来。 前一年 BAL的安全性已经确定，导致FDA的设计， 批准，行业支持的多中心临床试验，开始于 1996年初，确定BAL在等待肝脏移植的患者中的疗效 移植

Many patients with liver failure will die while awaiting transplantation. A Bioartificial Liver Assist System (BAL), a device using porcine hepatocytes, has been developed. During the previous year the safety of BAL had been established, leading to the design of an FDA approved, industry supported multicenter clinical trial which began in early 1996 to determine the efficacy of BAL in patients awaiting liver transplantation.